Cattle Futures Dip on South Korean Hold on US Beef Orders

Michael Teague  |

South Korea halted its imports of beef from the US on Wednesday, provoking a drop in cattle futures on the Chicago Mercantile Exchange.

Futures slated for December delivery were down 0.40 percent to $131.93 per pound on the CME, as a beef shipment originating from the US and under the custody of JBS S.A. (JBSAY) was found to contain the feed supplement Zilmax.

Christian Mayer, an advisor with Northstar Commodity Investments Co. in Minneapolis, Minnesota, told Bloomberg that “South Korea has been known to be picky at times,” and predicted a fairly serious backlash.

However, two of the largest cattle processors in the US, Cargill Inc. and Tyson Foods (TSN) have also recently refused to take shipments of beef that is shown to contain the supplement, so it is not entirely clear if South Korea is having one of its occasional bouts of “picky,” or if the country’s regulators are simply adhering to the nation’s zero-tolerance laws regarding hormones in livestock.

Furthermore shipments of Zilmax, produced by pharmaceutical giant Merck & Co. (MRK) , have already been suspended by the drug-maker itself since mid-August of this year in the US and Canada, after cattle who had consumed feed containing the supplement displayed great difficulty walking or even just standing.

With December futures down, Merck was also off by about 1.2 percent in midday trading to $47.20, while Tyson Foods was up over 2 percent to $28.90 per share.



[Image Courtesy of Flickr Creative Commons]

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to:


Symbol Name Price Change % Volume
TSN Tyson Foods Inc. 88.27 -0.61 -0.69 1,956,697 Trade
MRK Merck & Company Inc. (new) 83.02 0.51 0.62 6,656,690 Trade
ABPI Accentia Biopharmaceuticals Inc n/a n/a n/a 0



Symbol Last Price Change % Change






Can the Media Solve the Partisan Conflict?

Andrew McCarthy, Contributing Editor, The National Review; Michael Zeldin, CNN Legal Analyst; Celeste Katz, Senior Political Reporter, Glamour; Silvia Davi, SVP, Contributing Editor,; and Doug Simon, CEO, D S Simon Media discuss how the media’s role has shaped the landscape for communicators and what the media is trying to do to reduce discord in society.